Company / EPS (Basic)
Ensysce Biosciences, Inc. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$11.45
FY2025
5-year range
-$139.42 / -$11.45
FY2022-FY2025
Trend
+83.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-139.42 to $-11.45 over the past 2 years.
Based on SEC 10-K filings.
-11.45 in FY2025.
Improved from $-139.42 to $-11.45 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 83.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$11.45 | +83.7% |
| FY2024 | -$70.40 | +49.5% |
| FY2023 | -$139.42 | -370.4% |
| FY2022 | -$29.64 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026